Vera Therapeutics (VERA) Assets (2020 - 2026)

Vera Therapeutics has reported Assets for 7 years, with the latest figure at $621.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 1.9% year-over-year to $621.7 million; the trailing twelve-month figure through Mar 2026 stood at $621.7 million (up 1.9% YoY), and the FY2025 full-year result was $734.7 million, up 12.06% from the prior year.
• Assets for Q1 2026 stood at $621.7 million, down from $734.7 million in the prior quarter.
• The five-year high for Assets was $734.7 million in Q4 2025, with the low at $131.4 million in Q3 2022.
• Historically, Assets has averaged $366.8 million across 5 years, with a median of $368.6 million in 2024.
• Annual changes were most pronounced in 2024 — Assets surged 273.51% — and 2026, when it grew 1.9%.
• Vera Therapeutics' Assets stood at $131.4 million in 2022, then surged by 33.56% to $175.5 million in 2023, then surged by 273.51% to $655.7 million in 2024, then rose by 12.06% to $734.7 million in 2025, then dropped by 15.38% to $621.7 million in 2026.
• The last three Assets figures came in at $621.7 million (Q1 2026), $734.7 million (Q4 2025), and $517.5 million (Q3 2025), per Business Quant data.